Publications by authors named "Marie Lamiaux"
Article Synopsis
- * Among 181 AD patients, 14.9% had conjunctivitis at the start, with most seeing improvement by week 16, while 18.7% developed dupilumab-induced blepharoconjunctivitis, primarily as new cases.
- * Key risk factors linked to dupilumab-induced blepharoconjunctivitis included having AD on the head and neck, erythroderma, and existing dry eye syndrome, though baseline conjunctivitis severity wasn't a significant factor.
Potential role of tocilizumab in severe gastrointestinal barrier damage after CAR T-cell therapy.
J Microbiol Immunol Infect
April 2021
We report a septicemia and disseminated candidiasis due to delayed gastrointestinal mucosae repair in a patient treated with tocilizumab after anti-CD19 CAR T-cell therapy. Tocilizumab could have inhibited intestinal tissue repair and furthered bacteria translocation leading to the invasion of intestinal mucosa by yeasts as IL-6 is known to be involved in mucosal wound healing.
View Article and Find Full Text PDFTargeted therapy combination (TTC: antiRAF+antiMEK) is known to improve metastatic melanoma survival. Few severe skin toxicities (grade ≥3) are described with first-line TTC (17% for vemurafenib+cobimetinib and none for dabrafenib+trametinib) in a phase III trial. Among our 42 patients treated by TTC between January 2014 and March 2017, 4.
View Article and Find Full Text PDF